Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06043596

Evaluation of the SafeSpace App Intervention

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
Child Trends · Academic / Other
Sex
Female
Age
14 Years – 18 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to evaluate the impact of SafeSpace Sexual Health App, an innovative sexual health promotion program focused on reducing sexual risk factors and promoting sexual and reproductive health and wellbeing among young people assigned female or intersex at birth, particularly Black and/or Latine youth, LGBTQ+ youth, youth in states with high teen birth rates and youth who live in rural communities. This study utilizes a two-arm randomized control trial design to measure impacts of receiving the SafeSpace Sexual Health program compared to receiving a similar-length control app program, SafeSpace General Health that focuses on general health. The investigators will ask participants to: * Keep the SafeSpace app downloaded to their device and visit the app regularly over the course of 10 weeks. * Provide contact information. * Receive and open app push notifications for 10 weeks (up to 3 per week). * Complete 3 online surveys over a year: baseline, short-term follow-up (10 weeks after baseline), and long-term follow up (9 months after short-term follow-up). * Receive occasional text messages from the study team.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSafeSpace Sexual HealthThe overall goal of the program is to prevent adolescent pregnancy and STIs by increasing sexual agency, increasing the use of condoms and contraception, and promoting healthy relationships and healthy life skills among adolescents.
BEHAVIORALSafeSpace General HealthThis arm represents the comparison group. SafeSpace General Health will act as the active comparator, while providing youth with lessons, facts, and resources about general health topics.

Timeline

Start date
2023-06-12
Primary completion
2026-03-11
Completion
2026-09-29
First posted
2023-09-21
Last updated
2023-11-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06043596. Inclusion in this directory is not an endorsement.